ChiCTR-IIC-16010249
尚未开始
/
/
/
2016-12-22
/
/
卵巢多囊症
高能量聚焦式超音波（HIFU)治療無排卵性不孕的卵巢多囊症婦女之劑量研究
高能量聚焦式超音波（HIFU)治療無排卵性不孕的卵巢多囊症婦女之劑量研究
高能量聚焦式超音波（HIFU)治療無排卵性不孕的卵巢多囊症婦女之劑量
单臂
治疗新技术
NA
/
NA
/
30
/
1990-01-01
1990-01-01
/
1. Premenopausal women aged 18 to 40 years diagnosed with PCOS with anovulatory infertility; 2. Ability to give informed consent; 3. Body mass index <30 kg/m2; 4. Not on hormonal therapy (GnRH or combined oral contraceptive pills - COC) at the time of HIFU treatment; 5. No previous history of laparoscopic ovarian drilling or ovarian surgery; 6. Women with patent bilateral tubes; 7. Failure to achieve ovulation or pregnancy with incremental doses of clomiphene citrate; 8. Ability to give communicate clearly with a nurse or physician during HIFU treatment; 9. Women willing and able to comply with study requirements.；
请登录查看1. Pre-existing thyroid problem or hyperprolactinaemia which may cause anovulation; 2. Those with pre-existing compromised ovarian failure as evident by day 2 FSH >10IU/L or an AMH value of <0.75ng/ml before the treatment; 3. Pregnant or lactating; 4. Presence of active pelvic inflammatory disease, genital or extra-genital malignancy; 5. Extensive scarring along anterior lower abdominal wall (greater than 50% of area) or scar tissue or surgical clips in the direct path of the HIFU; 6. Unable to give consent or those who are unable for regular follow- ups after the study; 7. Those with an intrauterine device in situ; 8. Those with tattoos or metalic implants over their abdomen; 9. Male partner with moderate to severe male factor.；
请登录查看香港中文大學威爾斯親王醫院婦產科學系
/
皮肤好医荟2025-12-04
体外诊断原料网2025-12-04
优赛生命2025-12-04
医药时间2025-12-04
佰傲谷BioValley2025-12-04
求实药社2025-12-04
启迪之星2025-12-04
亚虹医药2025-12-04
幂方健康基金2025-12-04
汉氏联合2025-12-04
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
